Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 11/20 | 0.40 |
| ▸ | PPARA | Q07869 | 2/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 4/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | DRD1 | P21728 | 1/20 | 0.35 |
| ▸ | DRD4 | P21917 | 1/20 | 0.35 |
| ▸ | DRD5 | P21918 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25368354 | 0.88 | PPARD (0.39) | PPARDPPARAFFAR1ESR1ESR2 | |
| SCHEMBL25368248 | 0.87 | MTNR1A (0.40) | ESR1ESR2 | |
| SCHEMBL25366773 | 0.85 | XDH (0.38) | PPARDPPARAFFAR1ESR1ESR2 | |
| SCHEMBL25367772 | 0.78 | ALDH1A1 (0.41) | ESR1ESR2MEN1ALDH1A1GAA | |
| SCHEMBL25369795 | 0.75 | MTNR1A (0.44) | — | |
| SCHEMBL25366778 | 0.75 | PPARD (0.39) | PPARDPPARAFFAR1ESR1ESR2 | |
| SCHEMBL8255368 | 0.75 | ALDH1A1 (0.38) | MEN1ALDH1A1GAAMAPTHPGD | |
| SCHEMBL13390906 | 0.75 | ALDH1A1 (0.38) | MEN1ALDH1A1GAAMAPTHPGD | |
| SCHEMBL13958835 | 0.75 | ESR1 (0.66) | ESR1ESR2MEN1ALDH1A1GAA | |
| SCHEMBL13948427 | 0.75 | HTR2A (0.49) | PPARDESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12583809-B2 | Process for preparing indene acryladehyde derivatives | FIRMENICH SA (CH) | 2026-03-24 | — | — | US | disclosed |
| EP-4149913-B1 | PROCESS FOR PREPARING INDENE ACRYLADEHYDE DERIVATIVES | FIRMENICH & CIE (CH) | 2024-07-17 | — | — | EP | disclosed |
| US-20230271911-A1 | PROCESS FOR PREPARING INDENE ACRYLADEHYDE DERIVATIVES | FIRMENICH SA (CH) | 2023-08-31 | — | — | US | disclosed |
| CN-115768740-A | Process for preparing indene acrolein derivative | 弗门尼舍有限公司 | 2023-03-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12583809-B2 | Process for preparing indene acryladehyde derivatives | CBR1, CYP2E1, CYP2C8 | PPARD 2448/4885PPARA 2699/4885FFAR1 232/4885 |
| US-20230271911-A1 | PROCESS FOR PREPARING INDENE ACRYLADEHYDE DERIVATIVES | HPD, IMPDH1, IMPDH2 | PPARD 1736/4885PPARA 2775/4885FFAR1 2239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.